Ward Lantsheer
InvestorInvestment Analyst, Growth & Buy-Out Healthcare at Holland Capital
Amsterdam, North Holland, Netherlands
Experience
- Holland CapitalInvestment Analystcurrent2025 β present
- HC PartnersPrivate Equity2025
- Torqx Capital PartnersPrivate Equity2025
- EvommuneCorporate Strategy and Business Development2023Palo Alto, California, United States
- EurotransplantOrgan Transplantation Allocation Officer2018 β 2023Leiden
- Leiden Science - Universiteit LeidenResearch Intern2021 β 2022Leiden, South Holland, Netherlands
Education
- Leiden UniversityMSc, Bio-Pharmaceutical Sciences
- Leiden UniversityBSc, Bio-Pharmaceutical Sciences
Skills & more
Private Equity
From Ward's professional profile.
Colleagues at Holland Capital
Bente Sommeling
Investment Analyst at Holland Capital
Brenda van Baasbank
Investment Associate at Holland Capital
Christoph Thalhammer
Investment Analyst at Holland Capital
Coen Keijzer
Investment Associate at Holland Capital
Daan ten Haaf
Investment Associate at Holland Capital
Daan Wiersma
Investment Analyst at Holland Capital
David Langerhuizen
Investment Manager at Holland Capital
Ewout Prins
Managing Partner at Holland Capital
Frequently asked questions
- Where does Ward Lantsheer work?
- Ward Lantsheer is Investment Analyst, Growth & Buy-Out Healthcare at Holland Capital.
Same school
Also attended Leiden University76
Andrea van ElsasInvestor at Third Rock VenturesJoost HollemanInvestor at Prime VenturesFredric PetitPartner, Head of Materials & Packaging at Emerald Technology Ventures AgJeroen PlinkVenture Partner at LegalTechThijs SchaapInvestment manager at NoaberRoel BulthuisInvestor at Syncona
+ 70 more
Shared employers
Also worked at HC Partners1
Also worked at Torqx Capital Partners1
Also worked at Evommune7
Robert MittendorffGeneral Partner at B4 CapitalFelice Verduyn - Van WeegenPartner at EQT Life SciencesAllison GawPrincipal at Amplitude Venture CapitalRob HopfnerManaging Director at Pivotal Life SciencesYuexin YuDirector at Andera PartnersSonia HallenVice President at EQT Life Sciences
+ 1 more


























